Therapix Biosciences Ltd. (TRPX) Set to Announce Quarterly Earnings on Thursday
Therapix Biosciences (NASDAQ:TRPX) last released its earnings results on Thursday, August 10th. The company reported ($0.54) earnings per share for the quarter.
Therapix Biosciences Ltd. (NASDAQ TRPX) opened at $5.17 on Friday.
TRADEMARK VIOLATION WARNING: “Therapix Biosciences Ltd. (TRPX) Set to Announce Quarterly Earnings on Thursday” was originally posted by American Banking News and is owned by of American Banking News. If you are accessing this article on another publication, it was copied illegally and republished in violation of United States & international trademark & copyright laws. The legal version of this article can be read at https://www.americanbankingnews.com/2017/11/04/therapix-biosciences-ltd-trpx-set-to-announce-quarterly-earnings-on-thursday.html.
About Therapix Biosciences
Therapix Biosciences Ltd., a specialty clinical-stage pharmaceutical company, develops drugs based on cannabinoid molecules. Its drug development programs include Joint Pharma that develops THX-TS01 for the treatment of Tourette Syndrome (TS); and BrainBright Pharma, which develops THX-ULD01, a drug candidate based on an ultra-low dose of dronabinol for the treatment for mild cognitive impairment.
Receive News & Ratings for Therapix Biosciences Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Therapix Biosciences Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.